Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular ...

On World Cancer Day 2026, oncologists spoke about the early signs of prostate cancer, which are often mistaken for ...

Researchers at Moffitt Cancer Center have developed a new tool to predict how cancer cells evolve. By focusing on chromosome ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

“Oxybutynin demonstrated clear and clinically meaningful improvements in both hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer,” said lead researcher Dr.

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...